AU1294600A - Use of propionyl l-carnitine for the preparation of a medicament capable of inducing apoptosis - Google Patents

Use of propionyl l-carnitine for the preparation of a medicament capable of inducing apoptosis

Info

Publication number
AU1294600A
AU1294600A AU12946/00A AU1294600A AU1294600A AU 1294600 A AU1294600 A AU 1294600A AU 12946/00 A AU12946/00 A AU 12946/00A AU 1294600 A AU1294600 A AU 1294600A AU 1294600 A AU1294600 A AU 1294600A
Authority
AU
Australia
Prior art keywords
carnitine
propionyl
preparation
inducing apoptosis
medicament capable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12946/00A
Other languages
English (en)
Inventor
Menotti Calvani
Claudio Pisano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IT1998/000318 external-priority patent/WO2000027386A1/en
Priority claimed from IT1998RM000701A external-priority patent/IT1302858B1/it
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of AU1294600A publication Critical patent/AU1294600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU12946/00A 1998-11-11 1999-11-09 Use of propionyl l-carnitine for the preparation of a medicament capable of inducing apoptosis Abandoned AU1294600A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PCT/IT1998/000318 WO2000027386A1 (en) 1998-11-11 1998-11-11 Use of propionylcarnitine for the manufacture of a medicament for inhibiting smooth muscle cell proliferation
IT1998RM000701A IT1302858B1 (it) 1998-11-11 1998-11-11 Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento avente attivita' antitumorale.
ITRM98A0701 1998-11-11
WO800318 1998-11-11
PCT/IT1999/000357 WO2000027387A1 (en) 1998-11-11 1999-11-09 Use of propionyl l-carnitine for the preparation of a medicament capable of inducing apoptosis

Publications (1)

Publication Number Publication Date
AU1294600A true AU1294600A (en) 2000-05-29

Family

ID=26330215

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12946/00A Abandoned AU1294600A (en) 1998-11-11 1999-11-09 Use of propionyl l-carnitine for the preparation of a medicament capable of inducing apoptosis

Country Status (6)

Country Link
EP (1) EP1128823A1 (enExample)
JP (1) JP2002529408A (enExample)
KR (1) KR100694004B1 (enExample)
AU (1) AU1294600A (enExample)
CA (1) CA2350071A1 (enExample)
WO (1) WO2000027387A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101006207B1 (ko) * 2008-09-25 2011-01-07 김형호 잡음차단수단을 갖는 헤드셋

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
EP0681839A3 (en) * 1994-05-12 1997-11-12 Hirohiko Kuratsune A pharmaceutical preparation comprising an acylcarnitine
US5786326A (en) * 1995-02-03 1998-07-28 Horwitz; Lawrence D. Method for the treatment of atherosclerosis and vascular injury by prevention of vascular smooth muscle cell proliferation
IT1276253B1 (it) * 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
DK0793962T3 (da) * 1996-03-04 2000-05-22 Sigma Tau Ind Farmaceuti Lægemiddel indeholdende et carnitinderivat til behandling af arteriosclerosis obliterans
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di

Also Published As

Publication number Publication date
EP1128823A1 (en) 2001-09-05
KR20010080379A (ko) 2001-08-22
CA2350071A1 (en) 2000-05-18
JP2002529408A (ja) 2002-09-10
WO2000027387A1 (en) 2000-05-18
KR100694004B1 (ko) 2007-03-12

Similar Documents

Publication Publication Date Title
AU2180400A (en) A pharmaceutical combination for the treatment of depression
AU5259100A (en) Medicament
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU9187598A (en) Oral preparation
AU7582298A (en) Tissue specific prodrug
AU4210599A (en) Electronic pillbox for administering a multiple-drug therapy
AU1068400A (en) Shower head operating mechanism
AU1436900A (en) A job-parallel processor
AU2965199A (en) Medicine mini-chest
AUPQ137699A0 (en) Control of acidosis
AU8591898A (en) Pharmaceutical compounds
AU1025699A (en) Bathing implement
EP0681839A3 (en) A pharmaceutical preparation comprising an acylcarnitine
AU5762099A (en) The preparation of (n)-substituted-hydroxycycloalkylamine derivatives
AU7637996A (en) Preparation for dermatological use
AU6194298A (en) A process for the preparation of moenomycin A
AU6006898A (en) Skin preparation
AU1429200A (en) A processor
AU5799300A (en) Flexible helmet
AU5446499A (en) Apoptosis inducing agents
AU1688099A (en) Pharmaceutical preparation
AU1294600A (en) Use of propionyl l-carnitine for the preparation of a medicament capable of inducing apoptosis
AU2003274703A1 (en) Use of propionyl l-carnitine for the preparation of a medicament for the treatment of glaucoma
AU6550800A (en) Hepoxilin analogs
AU5472899A (en) Human angiopoietin-3

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase